Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer

Clinical trial NCT05447715 · UNKNOWN

Trial details

NCT number: NCT05447715
Sponsor: Weijian Guo
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2022-08-31
Primary completion: 2024-12-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.